论文部分内容阅读
目的:评价BiPAP无创呼吸机治疗慢性阻塞性肺病的临床疗效.方法:将70例慢性阻塞性肺病患者随机分为对照组和治疗组;对照组36例采用常规抗感染、平喘、止咳、化痰、雾化吸入等治疗,治疗组34例在上述治疗基础上予2周~4周BiPAP无创呼吸机治疗,IPAP12-20cmH2O,EPAP4~6cmH2O,每天6小时~8小时。结果:治疗组临床疗效总有效率为91.18%,对照组总有效率为69.44%,经X2检验,P<0.05,两组疗效有显著性差异。结论:无创呼吸机治疗慢性阻塞性肺病疗效显著。
Objective: To evaluate the clinical efficacy of BiPAP noninvasive ventilator in the treatment of chronic obstructive pulmonary disease.Methods: Seventy patients with chronic obstructive pulmonary disease were randomly divided into control group and treatment group.The control group received routine anti-infective, antiasthmatic, Sputum and inhalation therapy. 34 cases in the treatment group were treated with BiPAP non-invasive ventilator for 2 weeks to 4 weeks based on the above treatment, IPAP12-20cmH2O, EPAP 4-6cmH2O, 6 hours to 8 hours a day. Results: The total effective rate was 91.18% in the treatment group and 69.44% in the control group. There was significant difference between the two groups by X2 test (P <0.05). Conclusion: Noninvasive ventilator is effective in treating chronic obstructive pulmonary disease.